Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting

The rate of estrogen receptor‐conversion associated with tumor progression in estrogen receptor‐positive breast cancer patients following adjuvant Tamoxifen administration

Cancer Reports ◽

10.1002/cnr2.1431 ◽

2021 ◽

Author(s):

Sirus Djahansouzi ◽

Bettina Hanstein ◽

Daniel Rein ◽

Michel Clees ◽

Werner Rath

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Tumor Progression ◽

Cancer Patients ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Receptor Conversion ◽

P30. The use of HER2 receptors status as a prognostic index for estrogen receptor positive breast cancer patients

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-2-s2-p21 ◽

2014 ◽

Vol 2 (S2) ◽

Author(s):

A Tawfeek

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Prognostic Index ◽

Breast Cancer Patients ◽

FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients

Annals of Surgical Oncology ◽

10.1245/s10434-014-4313-2 ◽

2015 ◽

Vol 22 (6) ◽

pp. 2034-2039 ◽

Cited By ~ 15

Author(s):

Chenpu Xu ◽

Qun Wei ◽

Jufeng Guo ◽

Ji Chun Zhou ◽

Jin Mei ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Response To Chemotherapy ◽

Foxa1 Expression ◽

Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature

BMC Cancer ◽

10.1186/1471-2407-8-339 ◽

2008 ◽

Vol 8 (1) ◽

Cited By ~ 37

Author(s):

Andrew Tutt ◽

Alice Wang ◽

Charles Rowland ◽

Cheryl Gillett ◽

Kit Lau ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Distant Metastasis ◽

Risk Estimation ◽

Breast Cancer Patients ◽

Rt Pcr ◽

Node Negative ◽

Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor–Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial

Journal of Nuclear Medicine ◽

10.2967/jnumed.117.194654 ◽

2017 ◽

Vol 59 (2) ◽

pp. 197-203 ◽

Cited By ~ 12

Author(s):

Michel Paquette ◽

Éric Lavallée ◽

Serge Phoenix ◽

René Ouellet ◽

Helena Senta ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Estrogen Receptor ◽

Cancer Patients ◽

Phase Ii ◽

The Novel ◽

Breast Cancer Patients ◽

Ongoing Phase ◽

Abstract P3-05-16: The effect of HER-2/neu inhibition on prolonging clinical benefit with fulvestrant treatment for metastatic estrogen receptor positive breast cancer patients treated with trastuzumab

10.1158/1538-7445.sabcs14-p3-05-16 ◽

2015 ◽

Cited By ~ 1

Author(s):

Mahmoud Charif ◽

Elyse E Lower ◽

Diane Kennedy ◽

Harriet Kumar ◽

Shugufta Khan ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Clinical Benefit ◽

Breast Cancer Patients ◽

Her 2 ◽

Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05505-4 ◽

2019 ◽

Vol 179 (3) ◽

pp. 687-697

Author(s):

Min Hwan Kim ◽

Gun Min Kim ◽

Jee Hung Kim ◽

Jee Ye Kim ◽

Hyung Seok Park ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Poor Prognosis ◽

Her2 Expression ◽

Breast Cancer Patients ◽

Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients

BMC Cancer ◽

10.1186/s12885-018-4558-4 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 3

Author(s):

Elisabetta Venturelli ◽

Annalisa Orenti ◽

Aline S. C. Fabricio ◽

Giulia Garrone ◽

Roberto Agresti ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Observational Study ◽

Cancer Patients ◽

Prognostic Value ◽

Breast Cancer Patients ◽

Postmenopausal Estrogen ◽

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy

Acta Oncologica ◽

10.3109/0284186x.2011.653009 ◽

2012 ◽

Vol 51 (6) ◽

pp. 781-789 ◽

Cited By ~ 15

Author(s):

Mathilde S. Larsen ◽

Karsten Bjerre ◽

Anita Giobbie-Hurder ◽

Anne-Vibeke Lænkholm ◽

Katrine L. Henriksen ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Endocrine Therapy ◽

Prognostic Value ◽

Adjuvant Endocrine Therapy ◽

Breast Cancer Patients ◽

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen

The Pharmacogenomics Journal ◽

10.1038/tpj.2013.8 ◽

2013 ◽

Vol 14 (1) ◽

pp. 28-34 ◽

Cited By ~ 20

Author(s):

T Winder ◽

G Giamas ◽

P M Wilson ◽

W Zhang ◽

D Yang ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Clinical Outcome ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Receptor Polymorphism ◽